BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

KBC Group NV's Holding History (CIK: 0001411133)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 6,947 Value ($000) $0 Avg Close $7.23 Range $6.00 - $8.17

Q3 2025

Shares 6,947 Value ($000) $0 Avg Close $8.33 Range $7.42 - $9.23

Q2 2025

Shares 6,947 Value ($000) $0 Avg Close $9.31 Range $6.02 - $11.31

Q1 2025

Shares 10,198 Value ($000) $0 Avg Close $8.07 Range $6.96 - $9.50

Q4 2024

Shares 10,198 Value ($000) $0 Avg Close $7.59 Range $6.85 - $8.44

Q3 2024

Shares 5,661 Value ($000) $0 Avg Close $7.60 Range $6.17 - $8.88

Q2 2024

Shares 8,635 Value ($000) $0 Avg Close $5.52 Range $4.03 - $6.99

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	6,947	$0	$7.23	$6.00 - $8.17
Q3 2025	6,947	$0	$8.33	$7.42 - $9.23
Q2 2025	6,947	$0	$9.31	$6.02 - $11.31
Q1 2025	10,198	$0	$8.07	$6.96 - $9.50
Q4 2024	10,198	$0	$7.59	$6.85 - $8.44
Q3 2024	5,661	$0	$7.60	$6.17 - $8.88
Q2 2024	8,635	$0	$5.52	$4.03 - $6.99